France Cannabidiol Market Size & Outlook, 2024-2030
- Cannabis
- Cannabidiol & Cannabinoids
- Cannabidiol Market Outlook
- Cannabidiol & Cannabinoids
Global Market
Related Markets
Ask Prism AI anything about the cannabidiol market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
France cannabidiol market highlights
- The France cannabidiol market generated a revenue of USD 44.9 million in 2024 and is expected to reach USD 152.5 million by 2030.
- The France market is expected to grow at a CAGR of 22.6% from 2025 to 2030.
- In terms of segment, hemp was the largest revenue generating product in 2024.
- Hemp is the most lucrative product segment registering the fastest growth during the forecast period.
Cannabidiol market data book summary
| Market revenue in 2024 | USD 44.9 million |
| Market revenue in 2030 | USD 152.5 million |
| Growth rate | 22.6% (CAGR from 2025 to 2030) |
| Largest segment | Hemp |
| Fastest growing segment | Hemp |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hemp, Marijuana |
| Key market players worldwide | Medical Marijuana Inc, Canopy Growth Corp, Elixinol Wellness Ltd Ordinary Shares, The Cronos Group, Isodiol International Inc, Endoca, Folium Biosciences, NuLeaf Naturals, PharmaHemp |
Other key industry trends
- In terms of revenue, France accounted for 0.5% of the global cannabidiol market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Netherlands cannabidiol market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 191.8 million by 2030.
France is one of Europe's biggest cannabis consumers, but the drug remains illegal in the country. Only medicinal products made from cannabis derivatives are permitted and are prescribed when all other treatments have failed. In March 2021, the National Agency for the Safety of Medicines and Health Products launched a nationwide scheme allowing up to 3,000 patients to access cannabis based treatment for five specific conditions for free, with a prescription.
The trial, which was extended to March 2024, has produced positive clinical data. Benjamin-Alexandre Jean roy, the Co-Founder and CEO of Augur Associates, spoke to Lorna Rothery about the challenges of medical cannabis legalization in France and the possibility of harmonizing the industry across Europe.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cannabidiol Market Scope
Cannabidiol Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Canopy Growth Corp | View profile | 1,621 | 1 Hershey Drive, Smiths Falls, ON, Canada, K7A 0A8 | www.canopygrowth.com |
| The Cronos Group | View profile | 1001-5000 | Kontich, Antwerpen, Belgium, Europe | cronos-groep.be/ |
| Medical Marijuana Inc | View profile | 85 | 2384 La Mirada Drive, Vista, CA, United States, 92081 | www.medicalmarijuanainc.com |
| Elixinol Wellness Ltd Ordinary Shares | View profile | - | 680 George Street, Level 12, Sydney, NSW, Australia, 2000 | www.elixinolwellness.com |
| Isodiol International Inc | View profile | 197 | 200 Granville Street, Suite 2710, Vancouver, BC, Canada, V6C 1S4 | www.isodiol.com |
| Endoca | View profile | 1-10 | Hoofddorp, Noord-Holland, The Netherlands, Europe | www.endoca.com/pl |
| Folium Biosciences | View profile | 101-250 | Colorado Springs, Colorado, United States, North America | foliumbiosciences.com/ |
| NuLeaf Naturals | View profile | 51-100 | Denver, Colorado, United States, North America | nuleafnaturals.com/ |
| PharmaHemp | View profile | 51-100 | Ljubljana, Ljubljana Urban Commune, Slovenia, Europe | b2b.pharma-hemp.com |
France Cannabidiol Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Cannabidiol Market Outlook will help companies and investors design strategic landscapes.
Hemp was the largest segment with a revenue share of 54.79% in 2024.
Horizon Databook has segmented the France cannabidiol market based on hemp, marijuana covering the revenue growth of each sub-segment from 2018 to 2030.
France is one of Europe's biggest cannabis consumers, but the drug remains illegal in the country. Only medicinal products made from cannabis derivatives are permitted and are prescribed when all other treatments have failed. In March 2021, the National Agency for the Safety of Medicines and Health Products launched a nationwide scheme allowing up to 3,000 patients to access cannabis based treatment for five specific conditions for free, with a prescription.
The trial, which was extended to March 2024, has produced positive clinical data. Benjamin-Alexandre Jean roy, the Co-Founder and CEO of Augur Associates, spoke to Lorna Rothery about the challenges of medical cannabis legalization in France and the possibility of harmonizing the industry across Europe.
- France Cannabidiol Market Product Outlook (Revenue, USD Million , 2018-2030)
- Hemp
- Marijuana
- France Cannabidiol Market Sale Type Outlook (Revenue, USD Million , 2018-2030)
- B2B
- B2C
Reasons to subscribe to Cannabidiol Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Cannabidiol Market Outlook databook
- Our clientele includes a mix of Cannabidiol Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France Cannabidiol Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into France Cannabidiol Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
France Cannabidiol Market, 2018-2030 (US$M)
France cannabidiol market statistics, by product, 2018-2030 (US$M)
